These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25000353)

  • 41. Posterior myotomy/myectomy for persistent stooling problems in Hirschsprung's disease.
    Wildhaber BE; Pakarinen M; Rintala RJ; Coran AG; Teitelbaum DH
    J Pediatr Surg; 2004 Jun; 39(6):920-6; discussion 920-6. PubMed ID: 15185226
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Outpatient Botulinum Injections for Early Obstructive Symptoms in Patients with Hirschsprung Disease.
    Svetanoff WJ; Briggs K; Fraser JA; Lopez J; Fraser JD; Juang D; Aguayo P; Hendrickson RJ; Snyder CL; Oyetunji TA; St Peter SD; Rentea RM
    J Surg Res; 2022 Jan; 269():201-206. PubMed ID: 34587522
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transanal endorectal pull-through for classic segment Hirschsprung's disease: with or without laparoscopic mobilization of the rectosigmoid?
    van de Ven TJ; Sloots CE; Wijnen MH; Rassouli R; van Rooij I; Wijnen RM; de Blaauw I
    J Pediatr Surg; 2013 Sep; 48(9):1914-8. PubMed ID: 24074667
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of pelvic floor muscle training for the treatment of fecal incontinence after Soave procedure for Hirschsprung disease.
    Sun X; Wang R; Zhang L; Li D; Li Y
    Eur J Pediatr Surg; 2012 Aug; 22(4):300-4. PubMed ID: 22648188
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of Botulinum Toxin on Hirschsprung-Associated Enterocolitis After Primary Pull-Through.
    Rentea RM; Noel-MacDonnell JR; Bucher BT; Dorman MR; Lautz TB; Pruitt LCC; Oyetunji TA
    J Surg Res; 2021 May; 261():95-104. PubMed ID: 33422904
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterizing the use of botulinum toxin in patients with Hirschsprung disease treated at referral institutions for pediatric colorectal surgery.
    Rice-Townsend SE; Nicassio L; Glazer D; Avansino J; Durham MM; Calkins CM; Rentea RM; Ralls MW; Wood RJ; Rollins MD; Garvey EM; Lewis KE; Reeder R; Smith CA;
    J Pediatr Surg; 2022 Jun; 57(6):1033-1039. PubMed ID: 35292167
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intrasphincteric Botox injections in Hirschsprung's disease: indications and outcome in 64 procedures over a ten-year period.
    Pini Prato A; Faticato MG; Mazzola C; Arrigo S; Mattioli G; Arnoldi R; Mosconi M
    Minerva Pediatr (Torino); 2023 Aug; 75(4):482-489. PubMed ID: 30419742
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical outcome in children after transanal 1-stage endorectal pull-through operation for Hirschsprung disease.
    Zhang SC; Bai YZ; Wang W; Wang WL
    J Pediatr Surg; 2005 Aug; 40(8):1307-11. PubMed ID: 16080937
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of botulinum toxin injection and lateral internal sphincterotomy for the treatment of chronic anal fissure.
    Menteş BB; Irkörücü O; Akin M; Leventoğlu S; Tatlicioğlu E
    Dis Colon Rectum; 2003 Feb; 46(2):232-7. PubMed ID: 12576897
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment with botulinum toxin in children with chronic anal fissure.
    Husberg B; Malmborg P; Strigård K
    Eur J Pediatr Surg; 2009 Oct; 19(5):290-2. PubMed ID: 19746337
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hirschsprung's disease in children with Down syndrome: a comparative study.
    Travassos D; van Herwaarden-Lindeboom M; van der Zee DC
    Eur J Pediatr Surg; 2011 Aug; 21(4):220-3. PubMed ID: 21351043
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Botulinum toxin use in paediatric colorectal surgery.
    Basson S; Charlesworth P; Healy C; Phelps S; Cleeve S
    Pediatr Surg Int; 2014 Aug; 30(8):833-8. PubMed ID: 24997611
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Postoperative obstructive symptoms are common after Rehbein's procedure for Hirschsprung's disease.
    Wester T; Zetterlind L; Fredin K; Olsen L
    Eur J Pediatr Surg; 2006 Apr; 16(2):100-3. PubMed ID: 16685615
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Isosorbide dinitrate ointment vs botulinum toxin A (Dysport) as the primary treatment for chronic anal fissure: a randomized multicentre study.
    Berkel AE; Rosman C; Koop R; van Duijvendijk P; van der Palen J; Klaase JM
    Colorectal Dis; 2014 Oct; 16(10):O360-6. PubMed ID: 24629060
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Guidelines for the management of postoperative obstructive symptoms in children with Hirschsprung disease.
    Langer JC; Rollins MD; Levitt M; Gosain A; Torre L; Kapur RP; Cowles RA; Horton J; Rothstein DH; Goldstein AM;
    Pediatr Surg Int; 2017 May; 33(5):523-526. PubMed ID: 28180937
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Older age at diagnosis of Hirschsprung disease decreases risk of postoperative enterocolitis, but resection of additional ganglionated bowel does not.
    Haricharan RN; Seo JM; Kelly DR; Mroczek-Musulman EC; Aprahamian CJ; Morgan TL; Georgeson KE; Harmon CM; Saito JM; Barnhart DC
    J Pediatr Surg; 2008 Jun; 43(6):1115-23. PubMed ID: 18558193
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ten-year experience with the Swenson procedure in Nigerian children with Hirschsprung's disease.
    Sowande OA; Adejuyigbe O
    Afr J Paediatr Surg; 2011; 8(1):44-8. PubMed ID: 21478586
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sialorrhea & aspiration control - A minimally invasive strategy uncomplicated by anticholinergic drug tolerance or tachyphylaxis.
    Dohar JE
    Int J Pediatr Otorhinolaryngol; 2019 Jan; 116():97-101. PubMed ID: 30554718
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Transanal endorectal pull-through with short muscular cuff in the treatment of Hirschsprung disease. Preliminary study with 37 patients].
    Rintala RJ; Wester T
    Cir Pediatr; 2003 Oct; 16(4):161-5. PubMed ID: 14677352
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment and Patient Reported Outcome in Children with Hirschsprung Disease and Concomitant Congenital Heart Disease.
    Hasserius J; Hedbys J; Graneli C; Hagelsteen K; Stenström P
    Biomed Res Int; 2017; 2017():1703483. PubMed ID: 28373976
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.